Squarepoint
GDRX icon

Squarepoint’s GoodRx Holdings GDRX Stock Holding History

Squarepoint’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,100
Closed -$47K – 4869
2024
Q4 		$47K Buy
+10,100
New +$55.5K ﹤0.01% 4854
2022
Q1 		– Sell
-90,200
Closed -$2.95M – 3093
2021
Q4 		$2.95M Sell
90,200
-24,100
-21% -$970K 0.01% 1042
2021
Q3 		$4.69M Buy
114,300
+19,800
+21% +$718K 0.01% 805
2021
Q2 		$3.4M Buy
94,500
+57,300
+154% +$2.11M 0.01% 908
2021
Q1 		$1.45M Buy
+37,200
New +$1.67M 0.01% 1264

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SLG
Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PTC
Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return

Squarepoint's GDRX Position: Q1 2026 in Review

Squarepoint reduced its GoodRx Holdings (GDRX) stake by 9.4% in Q1 2026, selling an estimated $20.1K and leaving 82,716 shares worth $162K. The position accounts for ﹤0.01% of the portfolio, ranked #4002.

Squarepoint first reported a position in GDRX in Q3 2020 and has held it in 16 quarters since. The position peaked at $11.2M in Q3 2020. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

  • Squarepoint held 82,716 shares of GoodRx Holdings worth $162K as of Q1 2026.
  • Squarepoint sold 8,547 GoodRx Holdings shares in Q1 2026, an estimated $20.1K.
  • GoodRx Holdings made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #4002 holding.
  • Squarepoint first reported a position in GoodRx Holdings in Q3 2020 and has held it in 16 quarters since.
  • Squarepoint's GoodRx Holdings position peaked at $11.2M in Q3 2020.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.